PLUM ALLEY MANAGEMENT LLC

Thesis

Plum Alley aims to foster positive global change by investing in innovations that benefit humanity, industry, and the planet. They primarily focus on early-stage companies, particularly Series A rounds, seeking businesses with demonstrated customer traction and revenue, or drug discovery companies with a clear regulatory approval strategy or platform approach. Key sectors of interest include artificial intelligence and machine learning, biotech, climate solutions, alternative proteins, medical diagnostics, healthcare, and advanced systems. While headquartered in New York City, Plum Alley invests across the United States and globally, utilizing specialized funds and member syndicates. They often take a lead or co-investor role. Plum Alley Ventures Fund I, closed in December 2022, raised $22.4 million. As of September 2025, Plum Alley Ventures had deployed over $100 million across 32 companies. The firm's total assets under management are not publicly disclosed. The typical check size per investment deal is not explicitly stated, but they invest at the Series A level alongside other venture capital and institutional investors.

Related lists

• Seed-stage AI investors
• Seed-stage Climate investors
• Seed-stage Healthcare investors